[
  {
    "ts": null,
    "headline": "Charles River Laboratories International Inc. stock outperforms competitors on strong trading day",
    "summary": "Charles River Laboratories International Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=8e5d640d63c3ef1b2fe69b2bc0d71aa1bb47cf70a85b42f86c5cd5d017df9cb5",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747761720,
      "headline": "Charles River Laboratories International Inc. stock outperforms competitors on strong trading day",
      "id": 134681472,
      "image": "",
      "related": "CRL",
      "source": "MarketWatch",
      "summary": "Charles River Laboratories International Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=8e5d640d63c3ef1b2fe69b2bc0d71aa1bb47cf70a85b42f86c5cd5d017df9cb5"
    }
  },
  {
    "ts": null,
    "headline": "Should You Continue to Hold Charles River Stock in Your Portfolio?",
    "summary": "CRL stays on investors' radars due to the strength of partnerships and segmental prospects.",
    "url": "https://finnhub.io/api/news?id=bcf2899ce4fba59f2c9e297412ed6d543e0694d1b31161eb69e0b089429d3e82",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747745580,
      "headline": "Should You Continue to Hold Charles River Stock in Your Portfolio?",
      "id": 134629335,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "CRL stays on investors' radars due to the strength of partnerships and segmental prospects.",
      "url": "https://finnhub.io/api/news?id=bcf2899ce4fba59f2c9e297412ed6d543e0694d1b31161eb69e0b089429d3e82"
    }
  },
  {
    "ts": null,
    "headline": "Drug Development Inputs & Services Stocks Q1 Results: Benchmarking Charles River Laboratories (NYSE:CRL)",
    "summary": "Wrapping up Q1 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, including Charles River Laboratories (NYSE:CRL) and its peers.",
    "url": "https://finnhub.io/api/news?id=d801e0585e858eedb7b05153a1e1cdefb414065dfb185a32c64c7c95aa63f705",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747712061,
      "headline": "Drug Development Inputs & Services Stocks Q1 Results: Benchmarking Charles River Laboratories (NYSE:CRL)",
      "id": 134609517,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Wrapping up Q1 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, including Charles River Laboratories (NYSE:CRL) and its peers.",
      "url": "https://finnhub.io/api/news?id=d801e0585e858eedb7b05153a1e1cdefb414065dfb185a32c64c7c95aa63f705"
    }
  }
]